Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.70
-0.29 (-3.23%)
At close: Apr 28, 2026, 4:00 PM EDT
8.75
+0.05 (0.57%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Kyverna Therapeutics Employees
Kyverna Therapeutics had 130 employees as of December 31, 2025. The number of employees increased by 18 or 16.07% compared to the previous year.
Employees
130
Change (1Y)
18
Growth (1Y)
16.07%
Revenue / Employee
n/a
Profits / Employee
-$1,240,823
Market Cap
526.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 18 | 16.07% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Dec 31, 2023 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 300 |
| Rigel Pharmaceuticals | 174 |
| Sutro Biopharma | 137 |
| Ocugen | 116 |
| enGene Therapeutics | 82 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
| Altimmune | 57 |
KYTX News
- 6 days ago - Kyverna Therapeutics Transcript: Status update - Transcripts
- 7 days ago - Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting - GlobeNewsWire
- 8 days ago - Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks - GlobeNewsWire
- 19 days ago - Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026 - GlobeNewsWire
- 4 weeks ago - Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Kyverna Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026 - GlobeNewsWire
- 2 months ago - Kyverna Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire